Summary by Futu AI
On February 2, 2024, ProSomnus, Inc., a Delaware corporation, filed a post-effective amendment to its Form S-1 on Form S-3 with the Securities and Exchange Commission (SEC). This amendment is intended to convert the original registration statement into a registration statement on Form S-3 and to remove from registration the Convertible Note Shares that were previously registered, of which 230,494 have been sold. The company is also preparing for the primary offering of up to 6,512,087 shares of common stock upon the exercise of warrants, and a secondary offering of up to 9,850,363 shares of common stock and up to 2,411,848 warrants. ProSomnus, Inc. is known for manufacturing precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea. The company's common stock...Show More